On behalf of the Programming Committee and the Board of Directors of the CRS, I am truly delighted to invite you to join us in Las Vegas, Nevada for the 47th Annual Meeting of the Controlled Release Society to be held in the Paris Hotel June 27th – July 1st, 2020. This year, we have agreed upon the theme: “2020 Vision for Global Impact”, and we will be featuring a truly staggering set of speakers including Nobel Laureates, Academic thought leaders and Industry game changers that will cast a vision of the future of our field in the areas of drug delivery, material science, pharmaceutics, bioengineering, consumer and diversified products, and veterinary science.
Las Vegas is a perfect venue for this meeting not only for it’s exciting atmosphere, but also for its position in the world, being highly accessible to all of our members around the globe, and with increased proximity to our many members from Asia and Oceania. Las Vegas certainly has a tremendous number of thrilling things to see and do, but we are most excited about the stimulating and electrifying educational meeting content, that just keeps getting better every year. If you were able to join us in Valencia last year, you know what I am talking about. And if you missed the meeting in Valencia, you do NOT want to miss it again this year in Las Vegas.
Your presence at this year’s conference is an indication that you are committed to making a positive difference in creating the future of delivery science and technology by sharing scientific knowledge covering new technologies and science in the multi-disciplinary delivery field with colleagues from around the world. Meanwhile, I’m here to help you. If there is anything I can do for you, please do not hesitate to contact me.
In the meantime, check out Social Media for the hashtags #seeyouinVegas2020 and #CRS2020 and go to your calendar RIGHT NOW to put this meeting on your schedule for June 27th – July 1st, 2020.
Steve Little, PhD, Program Chair
William Kepler Whiteford Endowed Professor of Chemical Engineering, Bioengineering, Pharmaceutical Sciences, Immunology, Ophthalmology and The McGowan Institute for Regenerative Medicine at the University of Pittsburgh